Biobeat is proud to be part of the 5th Annual Cardiovascular Disease CVD Prevention Conference on April 11, 2026, where we will highlight advancements in blood pressure monitoring for early detection and prevention.
Tools like ambulatory blood pressure monitoring ABPM and 24 hr blood pressure monitors continue to play a critical role in identifying masked hypertension, but innovation is rapidly evolving beyond traditional ABPM devices.
At the event, discover our FDA cleared blood pressure monitor, designed as a discreet blood pressure monitoring patch that delivers continuous blood pressure monitoring without the need for cuffs. This cuffless blood pressure monitor functions as a continuous BP monitor, providing real time, clinically actionable insights.
We will be sharing how our FDA cleared, medical grade, validated cuffless blood pressure technology is transforming hypertension diagnosis and management, improving patient experience and outcomes.
Learn how the future of ambulatory BP monitoring is becoming more accurate, continuous, and patient friendly.